Martin-Blondel G, Marcelin AG, Soulie C, Kaisaridi S, et al. Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S CoCoPrev study). J Infect 2022 Apr 7. pii: S0163-4453(22)00196.
PMID: 35398409